TIM22-1 Antibody

What is TIM22 and what is its function in cells?

TIM22 is a translocase localized in the mitochondrial inner membrane that plays a critical role in mitochondrial protein import. It functions as the essential core component of the TIM22 complex, mediating the import and insertion of multi-pass transmembrane proteins into the mitochondrial inner membrane . Within this complex, TIM22 constitutes the voltage-activated and signal-gated channel, forming a twin-pore translocase that uses the membrane potential as an external driving force in two voltage-dependent steps . The protein has a calculated molecular weight of approximately 20 kDa and is also known by alternative names including TEX4, TIMM22, and "Testis-expressed protein 4" .

TIM22-1 antibodies have been tested and validated for reactivity with samples from multiple species:

When planning experiments with a new species, researchers should consider sequence homology and potentially validate the antibody with appropriate positive and negative controls before proceeding with full-scale experiments .

How should TIM22-1 antibodies be stored and handled?

For optimal performance and longevity, TIM22-1 antibodies require specific storage and handling conditions:

• Store at -20°C for long-term storage

• Antibodies are typically stable for one year after shipment when stored properly

• For the 14927-1-AP antibody, aliquoting is unnecessary for -20°C storage

• Some formulations (e.g., 20μl sizes) contain 0.1% BSA

• Avoid repeated freezing and thawing cycles to maintain antibody efficacy

• After reconstitution, some antibodies may remain stable at 2-8°C for up to 6 months

The antibodies are typically supplied in liquid form in storage buffer containing PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 .

How can I validate TIM22-1 antibody specificity for my experimental system?

Validating antibody specificity is critical for ensuring reliable experimental results. For TIM22-1 antibodies, a multi-pronged validation approach is recommended:

• Positive control testing: Use cell lines and tissues with known TIM22 expression. Recommended positive controls include HepG2 cells, MCF-7 cells, mouse liver tissue, and rat liver tissue for Western blot applications .

• Knockout/knockdown validation: Several publications have used TIM22 knockout or knockdown systems to validate antibody specificity. This approach provides the most stringent validation, as the signal should be absent or significantly reduced in samples lacking TIM22 .

• Molecular weight confirmation: Verify that the observed band appears at the expected molecular weight (approximately 20 kDa) . Both calculated and observed molecular weights for TIM22 are reported as 20 kDa .

• Cross-reactivity assessment: If working with multiple species, compare banding patterns across species to ensure consistent detection of the target protein.

• Multiple antibody approach: When possible, use antibodies from different vendors or those targeting different epitopes of TIM22 to confirm findings.

What are the optimal conditions for immunohistochemistry using TIM22-1 antibodies?

Successful immunohistochemistry (IHC) with TIM22-1 antibodies requires careful optimization of conditions:

How can I optimize Western blot protocols for TIM22-1 detection?

For optimal Western blot detection of TIM22, consider the following methodological details:

• Sample preparation: Total protein extraction from tissues should include mitochondrial fraction preservation. Since TIM22 is a mitochondrial protein, sample preparation methods that maintain mitochondrial integrity are crucial.

• Antibody dilution: While the recommended dilution range is 1:1000-1:8000 , specific optimal dilutions have been reported in the literature:

  • Ab167423 has been successfully used at 1/1000 dilution with various cell lysates (A673, T47D, A431, BxPC-3)

  • Ab251909 has been used at 0.4 μg/mL concentration

• Sample loading: Typically, 10 μg of cell lysate is sufficient for detection with these antibodies .

• Expected results: The predicted band size is 20 kDa , consistent with the calculated molecular weight of the protein.

• Blocking conditions: Standard blocking with 5% non-fat milk or BSA in TBST is generally effective, though specific optimization may be required for different experimental systems.

What controls should be included in experiments using TIM22-1 antibodies?

Robust experimental design requires appropriate controls to ensure valid interpretation of results:

What are the key considerations when designing co-localization studies with TIM22-1?

Co-localization studies can provide valuable insights into TIM22's interactions and functional context:

• Selection of markers: Pair TIM22-1 antibodies with established markers for:

  • Mitochondrial outer membrane (e.g., TOMM20)

  • Mitochondrial inner membrane (e.g., ATP synthase subunits)

  • Mitochondrial matrix proteins (e.g., HSP60)

  • Other components of the TIM22 complex

• Antibody compatibility: Ensure primary antibodies are from different host species (e.g., rabbit anti-TIM22 with mouse anti-TOMM20) to avoid cross-reactivity of secondary antibodies.

• Fixation and permeabilization optimization: Since TIM22 is located in the mitochondrial inner membrane, adequate permeabilization is critical for antibody access. Test multiple fixation protocols (4% PFA, methanol, or combinations) to determine optimal conditions.

• Imaging resolution: Use confocal microscopy or super-resolution techniques to accurately assess co-localization at the mitochondrial level, as standard epifluorescence may not provide sufficient resolution.

• Quantitative analysis: Apply appropriate co-localization metrics (Pearson's coefficient, Manders' coefficient) rather than relying solely on visual assessment of overlap.

What are common issues in Western blotting with TIM22-1 antibodies and how can they be resolved?

When troubleshooting, consider that TIM22 is a mitochondrial protein, so sample preparation methods that preserve mitochondrial integrity are crucial for consistent results .

How can I interpret contradictory results from different TIM22-1 antibodies?

When facing contradictory results using different TIM22-1 antibodies, consider the following analytical approach:

• Epitope differences: Different antibodies may target distinct epitopes of TIM22. For example, ab251909 recognizes an epitope within amino acids 50 to C-terminus , while A15312 was raised against the full-length protein (M1-D190) . Epitope accessibility may vary depending on experimental conditions or protein conformation.

• Antibody class differences: Compare results between polyclonal (14927-1-AP, ab251909, A15312) and monoclonal (ab167423) antibodies. Polyclonals recognize multiple epitopes and may provide higher sensitivity but potentially lower specificity than monoclonals.

• Validation status: Prioritize results from antibodies with more extensive validation (e.g., those with knockout/knockdown verification) .

• Application-specific optimization: An antibody performing well in one application (e.g., WB) may not be optimal for another (e.g., IHC). Verify that each antibody has been validated for your specific application.

• Cross-validation approach: When possible, confirm key findings using orthogonal methods (e.g., mass spectrometry, RNA expression analysis) that don't rely on antibody specificity.

How can TIM22-1 antibodies be used to study mitochondrial dysfunction in disease models?

TIM22-1 antibodies offer valuable tools for investigating mitochondrial dysfunction in various disease contexts:

• Neurodegenerative disorders: Changes in mitochondrial protein import machinery, including TIM22 complex, have been implicated in conditions like Parkinson's and Alzheimer's disease. TIM22-1 antibodies can help quantify alterations in expression levels across disease models and patient samples.

• Cancer metabolism: Cancer cells often exhibit altered mitochondrial function. Monitoring TIM22 expression using validated antibodies can provide insights into mitochondrial adaptations supporting cancer cell survival and proliferation.

• Metabolic disorders: In models of diabetes, obesity, and other metabolic conditions, TIM22-1 antibodies can help assess changes in mitochondrial protein import capacity as a potential contributor to pathogenesis.

• Aging research: Age-related decline in mitochondrial function may involve changes in protein import efficiency. TIM22-1 antibodies can be used to track changes in this machinery during aging processes.

• Drug development: When screening compounds targeting mitochondrial function, TIM22-1 antibodies can serve as tools to assess effects on protein import machinery.

For these applications, it's particularly valuable to use antibodies that have been extensively validated, such as those with published knockout/knockdown verification .

What emerging techniques can enhance the utility of TIM22-1 antibodies in research?

Several cutting-edge approaches can extend the applications of TIM22-1 antibodies:

• Proximity labeling: Combining TIM22-1 antibodies with proximity labeling techniques (BioID, APEX) can help identify novel interaction partners and map the dynamic protein landscape surrounding TIM22 in different physiological states.

• Single-cell analysis: Adapting TIM22-1 antibodies for use in single-cell protein analysis techniques can reveal cell-to-cell heterogeneity in mitochondrial protein import capacity within tissues.

• Quantitative proteomics: Using TIM22-1 antibodies for immunoprecipitation followed by mass spectrometry enables comprehensive analysis of the TIM22 complex composition under different conditions.

• Super-resolution microscopy: Combining TIM22-1 antibodies with techniques like STORM or PALM can provide nanoscale insights into the spatial organization of TIM22 within the mitochondrial inner membrane.

• In vivo imaging: Development of cell-permeable derivatized antibodies or antibody fragments against TIM22 could potentially enable live-cell tracking of mitochondrial protein import dynamics.

When implementing these advanced techniques, careful validation of antibody specificity becomes even more critical, particularly for approaches requiring high signal-to-noise ratios .